We all care
about someone
who will need medicines.
Our pipeline.
From target to the clinic. Our platform integrates biology, computation, and engineering to develop impactful antibody-based medicines.
People
connected.
Our work is measured by the number of people who are positively impacted by the medicines we make.
With
purpose.
We've bult a place where people feel they are part of something bigger than themselves. A place that exists to push the limits of science and technology.
People
connected.
This is a place that exists to push the limits of science and technology. A place focused on delivering breakthrough medicines that alleviate suffering, extend lives, and improve health.
With
purpose.
In the end, our success will be measured by the impact of our medicines.
Tiffany Mintah
Learning and Development Program Manager
AbCellera’s commitment to people, teams, and relationships is what drew me towards the company. I’m surrounded by brilliant, kind, and down-to-earth people every day, and I’m excited to contribute to this team.
Allie Goodman
Associate Scientific Director
Our family relocated to Vancouver from Boston — it’s a great place to raise our kids. We’re big hikers, bikers, and skiers, and take every chance we get to drive 25 min to the mountains and go on an adventure!
Peri Selevos
Senior Scientist
I love being part of a team where everyone’s ideas are heard. We work together to solve problems and make things happen, which makes coming to work something I actually look forward to—even on Mondays!
Callum Costello
Scientist I
There’s a tangible impact from the work I do as we move towards bringing medicines to patients. And I get to do that inspirational work in Vancouver, where I’m surrounded by incredible nature!
We have grown from six scientists in a lab to a company of ~600 people with fully integrated capabilities for creating first-in-class and best-in-class antibody medicines.
Since 2015, we have worked with more than 40 partners on 100+ antibody drug programs, solving some of the most difficult problems in the industry.
We have built a competitive advantage in the creation of antibody-based medicines. We are using our technology platform to advance programs involving complex transmembrane proteins, bispecifics, and antibody drug conjugates.
We hire for character and intelligence.
Driven by science.